chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tested positive for Covid; tested positive for Covid; booster shot of the Pfizer COVID vaccination; This is a spontaneous report received from a contactable consumer (patient's wife) from medical information team.  A 53-year-old male patient received bnt162b2 (BNT162B2), administration date 14Dec2021 16:20 (Batch/Lot number: unknown) at the age of 53 years as dose 3, (booster) single, administration date Feb2021 (Batch/Lot number: unknown) as dose 2, single and administration date Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Type II Diabetes" (unspecified if ongoing), notes: Diagnosed maybe 10 years ago. There were no concomitant medications. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 17Dec2021, outcome "unknown" and all described as "tested positive for Covid"; IMMUNISATION (medically significant) with onset 14Dec2021, outcome "unknown", described as "his booster shot of the Pfizer COVID vaccination". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (17Dec2021) positive. Additional information: The patient started coughing after the vaccine and tested positive for Covid on 17Dec2021 with an at home antigen test. The patient wanted to know if Pfizer had information on individuals who have tested positive after the booster dose with an antigen test. The reporter clarified that with the first Pfizer COVID vaccination, the patient had a fever, body aches, chills, all that for a couple days. This time, with the booster, the patient had all the same things the second day. On 16Dec2021, the patient felt pretty good, but on 17Dec2021, he was coughing a little bit and tested at work. The test came back positive, and he did not know if it was right.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Client felt dizzy, mouth and upper throat went numb, chest tight, shakey, felt terrible.  Seeing double and nauseated.  went to ER and received IV benadryl and relieved many symptoms but had heart rate escalating and dizzy continuously.  Body aches
Swollen lymph glands; Headache; Arm Pain; Fever; First dose on 02Feb2021, second dose on 19Feb2021; First dose on 02Feb2021, second dose on 19Feb2021; This is a spontaneous report from a contactable healthcare professional reported for herself. This 48-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number El9262) on 19Feb2021 at 08:45 AM single dose at left arm for COVID-19 immunisation. Medical history included known allergies: Penicillin, sulfa and Pre diabetic. Historical vaccine was 1st dose of BNT162B2 (lot number El3247) for COVID-19 immunisation on 02Feb2021 at 08:00 AM at left arm. Concomitant drugs included semaglutide (OZEMPIC), pravastatin sodium (PRAVASTINE), metformin and losartan potassium (LOSARTIN). On 19Feb2021 at 06:00 PM, the patient experienced headache, arm pain, fever and worst part was the swollen lymph glands. The patient had visible swollen under arm into breast and down side of her arm, almost looks like a half a baseball sticking out of her arm. The patient saw doctor on 22Feb2021 and received treatment. The outcome of the events was resolving.
No adverse event has occured.  Patient was administered the 5-11 dose pfizer vaccine without dilution.
three patients that had clots after the covid vaccine; This is a spontaneous report received from contactable reporter(s) (Other HCP).  A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: THROMBOSIS (medically significant), outcome "unknown", described as "three patients that had clots after the covid vaccine". Therapeutic measures were taken as a result of thrombosis.  Clinical Course: Report about the unexpected outcome/effect of bivalent covid 19 Pfizer vaccine outcome after treatment. Patient gender was unknown (3 patients not one- she works in Cardiology -hospital also). It was also stated that "I am vaccinated myself with the bivalent and booster. I believe in the vaccine, however I got recently three patients that had clots after the covid vaccine and they had to be in heparin for 6 months) I would like studies about this problem from the scientific point". It was clear the adverse event took place AFTER Pfizer Product USE. On Sunday, 12Feb2013 at 4:15pm mst (yes, I confirm the visit actually took place on Sunday at a Urgent care facility)  The information on the batch/lot number for [BNT162B2 NOS] has been requested and will be submitted if and when received.; Sender's Comments: Based on the available information and close temporal association, a possible causal relationship cannot be excluded between the suspect vaccine BNT162b2 NOS and the reported event thrombosis. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.,Linked Report(s) : US-PFIZER INC-PV202300028560 Different patients, Same reporter, drug, event.;US-PFIZER INC-202300067082 Different patients, Same reporter, drug, event.;
pt recv vax & exp stinging;pt arm was uncomfortable for 24hr;no tx was given;
Approx 1 inch red/pink circle, warm to the touch muscle soreness, still as of 10/12/2010 but coloring + warmth gone.
Chills followed by fever. Pain at injection site. Chills and fever were treated with ibuprofen.
pt admitted to hosp p/vax w/sz; parents described episode @ home, but no react in hosp; admitted for 24 hrs obs. hx of sx, but none since age 6 mo;
Shoulder pain bursitis, tendonitis of shoulder and shoulder pain, aching all day all night, unable to sleep due to pain. Treatment - cortisone shot - worked for 18 hours. 4 weeks of physical therapy, no relief still attempting physical ther.
Hep B vaccine given 11:30 AM.  Onset of shortness of breath, vertigo, pale noted at 13:00 after return to school.  Benadryl given by mouth.  Picked up at school by parent.  Telephone contanct with parent at 14:45 and again at 16:30.  Today child in no distress, no further problems noted.  Parent consulted with MD's ofice by phone.  No OV made for evaluation.
I felt like I had a bowling ball inside my stomach that was being pushed up through my throat.  Forced myself to throw up to relieve pressure and acid 4 different times.  Unable to get comfortable enough to sleep until the next morning.  Took Alka seltzer, drank water and club soda.  12 tough hours
devel hives over trunk&arms;very fussy 24hr p/inj;no fever;no resp problems;
Pt stated she had a reaction to the Covid-19 vaccine. Pt states she cannot raise her arm, where she got the injection is very hot to the touch, and she has pain all the way up to her neck. A slight knot at injection site.
felt uncomfortable after receiving Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of DISCOMFORT (felt uncomfortable after receiving Moderna vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DISCOMFORT (felt uncomfortable after receiving Moderna vaccine). At the time of the report, DISCOMFORT (felt uncomfortable after receiving Moderna vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient not sure after which dose event occurred. No relevant concomitant medications reported. No treatment information was provided.   This case was linked to MOD-2021-095271 (Patient Link).   Reporter did not allow further contact
On 01-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced DIARRHOEA (Diarrhea) and ABDOMINAL PAIN (Severe colon pain). On 03-Feb-2021, DIARRHOEA (Diarrhea) had resolved. At the time of the report, ABDOMINAL PAIN (Severe colon pain) outcome was unknown. Not Provided          Patient's concomitant drugs included heart medications, thyroid medications and cholesterol medications.  No corrective treatment was provided.
CDC Reports that 3 mo old infant received 1st DTP/OPV on 1DEC89 & died 3DEC89.
1cm macules, erythematous area lt thigh (site of DTP) & evenly dispersed on trunk & extremities;
Two days after receiving first dose of Pfizer COVID vaccine started feeling generally unwell. On the third day, started feeling progressively worse: dizziness upon standing and while standing (to the point I thought I would fall over) nausea, dry heaving, headache bordering on migraine, abdominal pain and a short period of appetite loss. Today (fourth day post shot) I called out of work and feel as if I?m on a tilt table while laying down, and will feel dizzy and nauseated immediately upon standing up. This is is spite of staying hydrated and eating a bland diet in order to not upset my stomach.
Patient was in decline in the last month due to increase weakness and increase edema. Daughter visited, found patient unresponsive, taken to hospital - found to be Covid Positive. Patient had had a 15lbs weight loss, had become bed bound, SOB on minimum exertion, incontinent of bowel & bladder. Patient had a pacemaker placed 3 weeks ago. Patient taken to hospice
Received dose from Vial punctured more than 12 hours before; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received dose from Vial punctured more than 12 hours before) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047B21A and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Sep-2021 at 8:40 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 03-Sep-2021 at 8:40 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received dose from Vial punctured more than 12 hours before). On 03-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Received dose from Vial punctured more than 12 hours before) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not  provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow up received on 07-SEP-2021 contains Non-Significant information-Reporter information added, vaccine route of administration, specific anatomical site updated.
This spontaneous report as received from a medical assistant refers to her 2-month-old (also reported as 4 months of age) daughter with no drug reaction nor allergies. The patient's medical history included acid reflux. In approximately March 2016 (reported as at her two month check up), the patient was inadvertently vaccinated with a dose of VAQTA (lot#, expiration date, dose, route and site of administration were not reported. Concomitant therapies included two other unspecified vaccines. In approximately 2016 (reported as at an unspecified time after the injection), the patient presented with a knot, fever and irritability. No lab diagnostics studies were performed. The patient was treated with unspecified dose of TYLENOL. The patient was doing alright at the time of this report. The outcome of events was not reported. The relatedness between knot, fever and irritability and VAQTA was not reported. Additional information has been requested.
At approximately 8pm the day of the vaccination, I felt fatigued. I woke up the next morning feeling like I was definitely sick with the typical symptoms. I was resting all morning on the couch at the house I was dog sitting. At around 11:30am I took my daily Claritin and two ibuprofens. At around 12:15pm, I was getting my haircut and felt like I was going to pass out. I asked the hairstylist to grab water and something to cool me off. I didn't have much control of my body, ED was called, and paramedics showed up. About 5 minutes into the incident my arms and legs started tingling and felt like someone was trying to twist my skin. An IV was put into me and about 5 minutes later I snapped out of the episode.
Within 4-5 hours of receiving the shot, I developed a dry cough, became very tired, then came down with severe chills.  I took an aspirin then went to bed. The symptoms passed within about 5-6 hours, and I was perfectly fine after that time.
developed a rash 3 inches long and 1 inch wide at the injection site; big red circle; couldn't sleep; a little warm; Shoulder very sore; Pain at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (couldn't sleep), VACCINATION SITE WARMTH (a little warm), ARTHRALGIA (Shoulder very sore), VACCINATION SITE PAIN (Pain at the injection site) and VACCINATION SITE RASH (developed a rash 3 inches long and 1 inch wide at the injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced INSOMNIA (couldn't sleep), VACCINATION SITE WARMTH (a little warm), ARTHRALGIA (Shoulder very sore) and VACCINATION SITE PAIN (Pain at the injection site). On 23-Feb-2021, the patient experienced VACCINATION SITE RASH (developed a rash 3 inches long and 1 inch wide at the injection site) and VACCINATION SITE ERYTHEMA (big red circle). At the time of the report, INSOMNIA (couldn't sleep), VACCINATION SITE WARMTH (a little warm), ARTHRALGIA (Shoulder very sore), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE RASH (developed a rash 3 inches long and 1 inch wide at the injection site) and VACCINATION SITE ERYTHEMA (big red circle) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No relevant concomitant medications were reported.  Treatment details included Benadryl (diphenhydramine HCL) and ibuprofen.
My first time is just sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Lot number: EW0164) at the age of 37 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), outcome "not recovered", described as "My first time is just sore". Therapeutic measures were taken as a result of pain.  Additional information: Treatment included Tylenol, 500mg she was taking 3 so its 1500, only taking twice a day .  No follow-up attempts are possible. No further information is expected.
sick; fever; chills; headache; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness, fever, chills and headache. On an unknown date, the outcome of the sickness, fever, chills and headache were unknown.   It was unknown if the reporter considered the sickness, fever, chills and headache to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 25-MAY-2022 Reporter's Comments: This case was reported via interactive digital media described the occurrence of sickness in for an unspecified number of patients.  who received Herpes zoster (Shingles vaccine) for prophylaxis.  The case was reported by reporter via interactive digital media. After receiving Shingles vaccine, The reporter mentioned that, the patient's physician warn several patient's got this kind of a reaction (sickness sick with fever, chills and headache. The reporter stated that it seemed better than how people would described their shingles here. The follow-up would not possible as no contact details were available. This case has been linked with case US2022AMR084987 as reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR084987:Same reporter
INJECTION SITE PAIN/SORENESS; INSOMNIA x1 DAYS; NIGHT SWEATS x2 DAYS; INSOMNIA x2 DAYS; SUBJECTIVE FEVER x2 DAYS; SEVERE HEADACHE, CONSTANT; NAUSEA, CONSTANT; VOMITTING, x2 INSTANCES, MALAISE, CONSTANT; FATIGUE, CONSTANT; ALL INTERFERE WITH AND/OR PREVENT ADL. AEs CURRENT THROUGH TIME AND DATE OF SUBMISSION ONLY. NOT YET RESOLVED.
Information has been received from a physician at health conference, concerning her 15 year old daughter with a history of bleeding gums (attributed to orthodontic braces) previous 7 days, menstruation heavier 7 days earlier, slight sore throat approximately 1 week prior, and infectious mononucleosis showed possible acute infection, but seroconversion did not occur until 05-FEB-2007, possibly delayed by prolonged steroid treatment.  On 03-OCT-2006, the patient was vaccinated with first dose of HPV vaccine. No reaction occurred. On 24-NOV-2006, the patient was vaccinated with second dose of HPV vaccine (lot # not reported), one month after the first dose. No reaction occurred.  On 12-DEC-2006, poliovirus vaccine boosterix injection was given. A 5cm bruise developed within 4 hours. On 12-DEC-2006, the patient was hospitalized with a platelet count greater than 5. Signs included: 4 cm hematoma at the site of immunization left upper arm, few petechiae on lower abdomen, no hepato-splenomegaly. Provisional diagnosis of immune thrombocytopenia (ITP) was made. The patient was treated with Prednisone 75 mg stat, 3 weeks of 50 mg Prednisone, followed by decreasing dose over the next month. By 29-JAN-2007, the patient's platelet count slowly returned to normal.  The physician commented: "This is case of ITP, probably due to infectious mononucleosis, but diagnosed 18 days after the second dose of HPV vaccine (symptoms started approximately 10 days after the vaccine). I am hopeful it was due to Glandular fever but an interesting co-incidence and an unusual presentation of "IW." Additional information has been requested.
Pt has IM phizer injection   one day later developed fevers, headaches body aches that lasted ten days. Was  not able to work. I called her up early February and she had recovered from these.
Patient was seen in clinic today. She began having headache the day after injection and 3 days later a rash. She was diagnosed with Shingles involving the right trigeminal nerve
Information has been received from an MA concerning a 75 year old white male who on 12/5/00 was vaccinated, IM, with pneumococcal vaccine 23 polyvalent (lot 637094/0945K). Subsequently, on 12/6/00, the pt experienced increased swelling and erythema of the upper arm that was considered an "Other Medical Event". Subsequently, the pt recovered "spontaneously". This was the pt's booster dose. The pt had no reaction with previous dose. Unspecified medical attention was sought. No further information is not expected.
7 days post administration, left arm experienced significant redness, itching, heat and swelling.  The reaction spread for the next 48 hours then dissipated.  The reaction was approximately 6 inches in diameter at its greatest size.
The first shot in January gave me migraines on and off over the next 5 days, based on the left side of my head.  I usually get a migraine before my period, but always on my front right area behind my eye and above my ear, and only for 1 day. It was noticeable because they kept coming back and it was in a place I've never had a migraine start.  The second shot however on 2/9/21 is my main concern. my period was just ending after about 4 days.  a bit of spotting, but it was basically done. The next day after my shot though, I woke up soaked in blood. I spent the next 7-8 hours going through 7 Super-size Tampax Tampons. It seemed like I was flash flooding blood  which was weird because ..well if my lining had just shed over the previous 7 days, where did all the blood come from? It ebbed within 24 hours and was back to normal the day after that before it ended.  Over by 2/12/21.  And now, it is 5/3/21 and I have not had a period since and have basically had early menopause jump in and get hot flashes every day! I read that its not actually menopause until our period has been gone for 6 months or more, and mine has really only been nearly 3, but I'm pretty sure I just got sterilized.  And I was a healthcare worker so I got it early, and I don't think the older people getting the shot in line before me would have been raising the concern about their menses cycles because they don't have them anymore.
Patient called today said that her left leg  doesn't fell the same as before the 2 nd IMZ of the Shingrix.  She got the 1 st shot on 02/29/20 and the 2 nd one on 07/25/20. She noticed after the  2 nd shot. She said maybe swelling, little pain and she said she will contact her Dr's office to see if anything else going on.
Localized reaction Induration 1.5"; localized reaction Itching; Localized reaction Swollen; Localized reaction Red; This case was reported by a nurse via call center representative and described the occurrence of induration in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABXA95AA, expiry date 28th February 2022) for prophylaxis.   On 10th September 2020, the patient received the 1st dose of Bexsero. On an unknown date, less than 2 months after receiving Bexsero, the patient experienced induration, localized itching, local swelling and localized erythema. On an unknown date, the outcome of the induration, localized itching, local swelling and localized erythema were recovered/resolved.   It was unknown if the reporter considered the induration, localized itching, local swelling and localized erythema to be related to Bexsero.  Additional details were reported as follows: The patient received dose of Bexsero and experienced localized reaction of induration 1.5 inch, itching, swollen and red which lasted for more than 3 weeks. No other information was available. The reporter did not consent to follow up. The batch number ADXA95AA, however captured as ABXA95AA as per sales sheet.
After receiving vaccine, woke up around 3 am experiencing nausea, loss of vision x 1-2 minutes, syncope, difficulty breathing, numbness & tingling in hands and feet.  Measured temperature of 102 F.  Slept most of the next day and missed work x 1 day.  The following day was improved but still with moderate fatigue and nausea.  Took ibuprofen with some improvement.